Description
Cagrilintide 5mg – Long-Acting Amylin Analog Research Compound
Cagrilintide is a long-acting amylin analog: a lipidated synthetic peptide engineered from the pancreatic hormone amylin, which is co-secreted with insulin. In modern metabolic research it is best known as the amylin-pathway counterpart to the incretin-family compounds, and it is frequently studied alongside GLP-1 receptor agonists such as semaglutide (GLP-1SG) in combination-pharmacology models. Supplied as 5mg of lyophilized peptide in a sterile sealed vial.
Product Details
- Common Name: Cagrilintide (amylin analog)
- Form: Lyophilized powder in a sterile sealed vial
- Amount: 5mg per vial
- Purity: ≥99% (HPLC verified, third-party tested)
- Molecular Formula: C170H260N50O54
- Molecular Weight: ~3258.7 Da
- CAS Number: 2227891-92-9
- Class: Long-acting lipidated amylin analog
- Storage: Cool, dry place; refrigerate after reconstitution
- Intended Use: For laboratory research use only
About Cagrilintide in Research
Amylin signaling regulates satiety and gastric-emptying pathways that are distinct from, and complementary to, incretin signaling. Cagrilintide’s extended half-life engineering makes it the standard research tool for studying the amylin receptor system, and for comparative and combination studies against GLP-1, dual, and triple agonist compounds.
Research Resources
Read our full guide, Cagrilintide: The Next-Generation Amylin Analog, and see how the incretin side compares in Semaglutide vs Tirzepatide. For bench preparation, use the reconstitution calculator with bacteriostatic water.
Notice: This material is supplied strictly for research purposes only. It is not intended for human or animal consumption.
